Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/12073051

Download in:

View as

General Info

PMID
12073051